146 related articles for article (PubMed ID: 30280953)
1. Major effects on blood-retina barrier passage by minor alterations in design of polybutylcyanoacrylate nanoparticles.
You Q; Hopf T; Hintz W; Rannabauer S; Voigt N; van Wachem B; Henrich-Noack P; Sabel BA
J Drug Target; 2019 Mar; 27(3):338-346. PubMed ID: 30280953
[TBL] [Abstract][Full Text] [Related]
2. How Nanoparticle Physicochemical Parameters Affect Drug Delivery to Cells in the Retina via Systemic Interactions.
You Q; Sokolov M; Grigartzik L; Hintz W; van Wachem BGM; Henrich-Noack P; Sabel BA
Mol Pharm; 2019 Dec; 16(12):5068-5075. PubMed ID: 31609624
[TBL] [Abstract][Full Text] [Related]
3. Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles.
Voigt N; Henrich-Noack P; Kockentiedt S; Hintz W; Tomas J; Sabel BA
Eur J Pharm Biopharm; 2014 May; 87(1):19-29. PubMed ID: 24607790
[TBL] [Abstract][Full Text] [Related]
4. In vivo visualisation of nanoparticle entry into central nervous system tissue.
Henrich-Noack P; Prilloff S; Voigt N; Jin J; Hintz W; Tomas J; Sabel BA
Arch Toxicol; 2012 Jul; 86(7):1099-105. PubMed ID: 22422342
[TBL] [Abstract][Full Text] [Related]
5. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles.
Kuo YC; Su FL
Int J Pharm; 2007 Aug; 340(1-2):143-52. PubMed ID: 17418986
[TBL] [Abstract][Full Text] [Related]
6. The first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood-brain barrier permeation.
Weiss CK; Kohnle MV; Landfester K; Hauk T; Fischer D; Schmitz-Wienke J; Mailänder V
ChemMedChem; 2008 Sep; 3(9):1395-403. PubMed ID: 18613205
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.
Wohlfart S; Khalansky AS; Gelperina S; Begley D; Kreuter J
J Control Release; 2011 Aug; 154(1):103-7. PubMed ID: 21616104
[TBL] [Abstract][Full Text] [Related]
8. Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity.
Rempe R; Cramer S; Hüwel S; Galla HJ
Biochem Biophys Res Commun; 2011 Mar; 406(1):64-9. PubMed ID: 21295549
[TBL] [Abstract][Full Text] [Related]
9. Polybutylcyanoacrylate nanoparticles as novel vectors in cancer gene therapy.
Zhang Y; Zhang Y; Chen J; Zhang B; Pan Y; Ren L; Zhao J; Luo Y; Zhai D; Wang S; Wang J
Nanomedicine; 2007 Jun; 3(2):144-53. PubMed ID: 17468053
[TBL] [Abstract][Full Text] [Related]
10. Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier.
Kuo YC; Chen HH
Int J Pharm; 2006 Dec; 327(1-2):160-9. PubMed ID: 16939704
[TBL] [Abstract][Full Text] [Related]
11. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
Gao K; Jiang X
Int J Pharm; 2006 Mar; 310(1-2):213-9. PubMed ID: 16426779
[TBL] [Abstract][Full Text] [Related]
12. [Carrier-mediated Transport of Cationic Drugs across the Blood-Tissue Barrier].
Kubo Y
Yakugaku Zasshi; 2015; 135(10):1135-40. PubMed ID: 26423869
[TBL] [Abstract][Full Text] [Related]
13. Effect of surfactant on fabrication and characterization of paclitaxel-loaded polybutylcyanoacrylate nanoparticulate delivery systems.
Mitra A; Lin S
J Pharm Pharmacol; 2003 Jul; 55(7):895-902. PubMed ID: 12906746
[TBL] [Abstract][Full Text] [Related]
14. Transcytosis of CRM197-grafted polybutylcyanoacrylate nanoparticles for delivering zidovudine across human brain-microvascular endothelial cells.
Kuo YC; Chung CY
Colloids Surf B Biointerfaces; 2012 Mar; 91():242-9. PubMed ID: 22137614
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity and apoptotic gene expression in an in vitro model of the blood-brain barrier following exposure to poly(butylcyanoacrylate) nanoparticles.
Hall AM; Hemmer R; Spaulding R; Wetzel HN; Curcio J; Sabel BA; Henrich-Noack P; Pixley S; Hopkins T; Boyce RL; Schultheis PJ; Haik KL
J Drug Target; 2016 Aug; 24(7):635-44. PubMed ID: 26707984
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Polybutylcyanoacrylate Nanoparticles as a Protos Delivery Vehicle on Dental Bone Formation.
Chang LC; Chung CY; Chiu CH; Lin MH; Yang JT
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062952
[TBL] [Abstract][Full Text] [Related]
17. Enhanced anti-tumor effects of doxorubicin on glioma by entrapping in polybutylcyanoacrylate nanoparticles.
Zhang Y; Yu J; Zhang L; Cai J; Cai D; Lv C
Tumour Biol; 2016 Feb; 37(2):2703-8. PubMed ID: 26404136
[TBL] [Abstract][Full Text] [Related]
18. Effects of phospholipid and polyethylene glycol monostearate (100) on the in vitro and in vivo physico-chemical characterization of poly(n-butyl cyanoacrylate) nanoparticles.
Jin X; Asghar S; Zhang M; Chen Z; Zhang J; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2019 Jan; 173():320-326. PubMed ID: 30312943
[TBL] [Abstract][Full Text] [Related]
19. [Preparation of paclitaxel-loaded polybutylcyanoacrylate nanoparticles].
Chen RD; Ren F; Li GF; Liu SJ
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):763-6. PubMed ID: 20423845
[TBL] [Abstract][Full Text] [Related]
20. Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats.
Bagad M; Khan ZA
Int J Nanomedicine; 2015; 10():3921-35. PubMed ID: 26089668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]